The Center for Systems Immunology

 
Muhammad Latif
Muhammad Bilal Latif, DVM, PhD
Research Associate
Department of Pathology, School of Medicine
 

Dr. Bilal obtained a DVM from the University of Veterinary and Animal Sciences, Lahore, Pakistan. He then moved to Sweden to obtain MS in Molecular Biology with a major in Biotechnology. For his career in research, he went on to earn a Ph.D. in Veterinary Sciences (Virology-Immunology) from the University of Liege, Belgium. During his Ph.D., he studied the role of the ORF63 gene of MuHV-4 in virus entry, exit, and immune evasion. He discovered that the ORF63 is required during entry for the transport of MuHV-4 capsids from the cell membrane to the nucleus of the host cell. For his postdoctoral training, he joined the laboratory of Prof. Ganes C. Sen at Lerner Research Institute, Cleveland Clinic. There, he studied the relative contribution of cGAS-STING and TLR3 pathways in attenuation of HSV-1 infection and discovered that they contribute differently in different cells. He joined the lab of Prof. Rafick-Pierre Sekaly in March 2020.
 
Research Interests
 
Dr. Bilal’s current research interests include; studying the contribution of cGAS-STING signaling in HIV and COVID-19 (SARS Cov-2) infections, and developing antiviral therapies against these viruses.